Literature DB >> 29761260

Fetal Type Rhabdomyoma of the Soft Palate in an Adult Patient: Report of One Case and Review of the Literature.

Zhenjian Cai1, Jaiyeola Thomas1, Ibrahim Alava2, Nfn Aakash1, Karan Saluja1, Hui Zhu3.   

Abstract

Rhabdomyoma is a rare benign tumor with skeletal muscle differentiation. Rhabdomyoma is further classified into cardiac, adult, fetal, and genital subtypes. Out of these, fetal type rhabdomyoma (FTR) is the rarest. Only a small number of cases have been recorded in the literature. FTR typically affects male infants and young children and occurs predominantly in the head and neck region. FTR is exceedingly rare in the adult, with less than 30 cases reported. The classic FTR is composed of primitive undifferentiated spindle cells with scant eosinophilic cytoplasm embedded in a myxoid stroma. Immunohistochemically, the tumor cells are positive for desmin, muscle specific actin, and myogenin. Awareness and proper recognition of this rare entity is of considerable importance to avoid misdiagnosis of embryonal rhabdomyosarcoma. In this study, we report one case of FTR in an adult patient and reviewed the literature about the clinical and pathologic presentation of FTR in the adult.

Entities:  

Keywords:  Benign spindle cell tumor; Rhabdomyoma; Rhabdomyosarcoma

Year:  2018        PMID: 29761260      PMCID: PMC6514031          DOI: 10.1007/s12105-018-0931-5

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  2 in total

1.  Adult extracardiac rhabdomyomas presenting as a slowly growing neck mass.

Authors:  Omar Elmandouh; Elena Greco; Amit Agarwal
Journal:  Radiol Case Rep       Date:  2022-06-25

Review 2.  [The most common benign cutaneous neoplasms of vascular, muscular, and adipose tissue and their treatment].

Authors:  Alexandra-Irina Butacu; Iulia-Elena Negulet; Emanuela-Domnica Boieriu; Ioana-Simona Dinu; Andrew Mihalache; Bogdan Mastalier; Carmen Maria Salavastru; Klaus Fritz; George-Sorin Tiplica
Journal:  Hautarzt       Date:  2022-01-18       Impact factor: 0.751

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.